BioCentury
ARTICLE | Company News

MorphoSys Alzheimer's deal with Roche

September 11, 2000 7:00 AM UTC

MorphoSys (NMarkt:MOR) will use its HuCAL Fab technology to develop antibodies against a target from Roche (SWX:ROCZ). MOR will receive an upfront payment and be eligible for milestones and royalties ...